Page 101 - Read Online

Page 20 of 20 Ottewell et al. J Cancer Metastasis Treat 2021;7:11 https://dx.doi.org/10.20517/2394-4722.2021.14

60. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001;Chapter 20:Unit 20.2. DOI PubMed
61. Tulotta CM, Lefley DV, Amariutei AE, et al. Inhibition of breast cancer bone metastasis through Interleukin-1B regulated tumour-
associated innate immune response. Breast Cancer Res Treat 2020;180:538-9.
62. Hiraga T, Ninomiya T. Establishment and characterization of a C57BL/6 mouse model of bone metastasis of breast cancer. J Bone
Miner Metab 2019;37:235-42. DOI PubMed
63. Zhou JZ, Riquelme MA, Gao X, Ellies LG, Sun LZ, Jiang JX. Differential impact of adenosine nucleotides released by osteocytes on
breast cancer growth and bone metastasis. Oncogene 2015;34:1831-42. DOI PubMed PMC
64. Cox TC. Microcomputed tomography of craniofacial mineralized tissue: A practical user's guide to study planning and generating
quality data. Bone 2020;137:115408. DOI PubMed
65. Green AC, Lath D, Hudson K, et al. TGFβ Inhibition Stimulates Collagen Maturation to Enhance Bone Repair and Fracture Resistance
in a Murine Myeloma Model. J Bone Miner Res 2019;34:2311-26. DOI PubMed
66. Paton-Hough J, Tazzyman S, Evans H, et al. Preventing and Repairing Myeloma Bone Disease by Combining Conventional
Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models. J Bone Miner Res 2019;34:783-96. DOI PubMed PMC
67. Westbrook JA, Cairns DA, Peng J, et al. CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and
Treatment. J Natl Cancer Inst 2016:108. DOI PubMed PMC
68. Monteran L, Ershaid N, Sabah I, et al. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune
suppression in a model of spontaneous breast cancer metastasis. Sci Rep 2020;10:13838. DOI PubMed PMC
69. Yao L, Aryee K, Cheng M, Kaur P, Keck JG, Brehm MA. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology. In:
Moll J, Carotta S, editors. Target Identification and Validation in Drug Discovery. New York: Springer; 2019. pp. 241-52. DOI
PubMed
70. Hasgur S, Aryee KE, Shultz LD, Greiner DL, Brehm MA. Generation of Immunodeficient Mice Bearing Human Immune Systems by
the Engraftment of Hematopoietic Stem Cells. In: Proetzel G, Wiles MV, editors. Mouse Models for Drug Discovery. New York:
Springer; 2016. pp. 67-78. DOI PubMed PMC
71. Wege AK, Ernst W, Eckl J, et al. Humanized tumor mice-a new model to study and manipulate the immune response in advanced
cancer therapy. Int J Cancer 2011;129:2194-206. DOI PubMed